Ingrid Moen

1.3k total citations · 1 hit paper
16 papers, 934 citations indexed

About

Ingrid Moen is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Ingrid Moen has authored 16 papers receiving a total of 934 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Molecular Biology and 6 papers in Cancer Research. Recurrent topics in Ingrid Moen's work include Cancer, Hypoxia, and Metabolism (5 papers), Angiogenesis and VEGF in Cancer (4 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). Ingrid Moen is often cited by papers focused on Cancer, Hypoxia, and Metabolism (5 papers), Angiogenesis and VEGF in Cancer (4 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). Ingrid Moen collaborates with scholars based in Norway, United States and Germany. Ingrid Moen's co-authors include Linda Stuhr, Frits Thorsen, Cecilie Brekke Rygh, Jian Wang, Simone P. Niclou, Rolf Bjerkvig, Torfinn Taxt, Olivier Keunen, Fred Fack and Anaïs Oudin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and The Journal of Physiology.

In The Last Decade

Ingrid Moen

16 papers receiving 924 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma

2011 492 citations Olivier Keunen, Mikael Johansson et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ingrid Moen Norway	8	415	393	263	187	175	16	934
Matthew E. Hardee United States	17	373 0.9×	419 1.1×	327 1.2×	441 2.4×	232 1.3×	31	1.4k
Anh Tran United States	13	369 0.9×	419 1.1×	568 2.2×	173 0.9×	94 0.5×	20	1.0k
K. Jason South Korea	17	226 0.5×	354 0.9×	192 0.7×	249 1.3×	72 0.4×	48	814
Nicole Parker Australia	10	276 0.7×	388 1.0×	239 0.9×	391 2.1×	81 0.5×	16	1.1k
Sanne A. M. van Lith Netherlands	17	234 0.6×	382 1.0×	182 0.7×	246 1.3×	97 0.6×	33	881
Olivier Keunen Luxembourg	13	744 1.8×	754 1.9×	537 2.0×	253 1.4×	137 0.8×	23	1.5k
David L. Gillespie United States	19	417 1.0×	586 1.5×	368 1.4×	136 0.7×	98 0.6×	28	1.2k
Elizabeth Cohen‐Jonathan‐Moyal France	14	337 0.8×	519 1.3×	558 2.1×	217 1.2×	95 0.5×	25	1.2k
Rikke Hedegaard Dahlrot Denmark	18	319 0.8×	443 1.1×	544 2.1×	266 1.4×	68 0.4×	60	1.1k
Mario Caccese Italy	17	211 0.5×	253 0.6×	450 1.7×	242 1.3×	77 0.4×	70	883

Countries citing papers authored by Ingrid Moen

Since Specialization

Citations

This map shows the geographic impact of Ingrid Moen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingrid Moen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingrid Moen more than expected).

Fields of papers citing papers by Ingrid Moen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingrid Moen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingrid Moen. The network helps show where Ingrid Moen may publish in the future.

Co-authorship network of co-authors of Ingrid Moen

This figure shows the co-authorship network connecting the top 25 collaborators of Ingrid Moen. A scholar is included among the top collaborators of Ingrid Moen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingrid Moen. Ingrid Moen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Karlsson, Jenny, Franziska Siegel, Ingrid Moen, et al.. (2025). Abstract ND09: BAY 3547926: Novel targeted radionuclide therapy for hepatocellular carcinoma. Cancer Research. 85(8_Supplement_2). ND09–ND09. 1 indexed citations

Schatz, Christoph A., Sabine Zitzmann-Kolbe, Ingrid Moen, et al.. (2024). Preclinical Efficacy of a PSMA-Targeted Actinium-225 Conjugate (225Ac-Macropa-Pelgifatamab): A Targeted Alpha Therapy for Prostate Cancer. Clinical Cancer Research. 30(11). 2531–2544. 5 indexed citations

Suurs, Frans V., Ingrid Moen, Danique Giesen, et al.. (2022). ⁸⁹Zr-3,2-HOPO-mesothelin antibody PET imaging reflects tumor uptake of mesothelin targeted ²²⁷Th-conjugate therapy in mice. Journal of Nuclear Medicine. 63(11). jnumed.121.263079–jnumed.121.263079. 6 indexed citations

Moen, Ingrid, et al.. (2022). TAK1-inhibitors did not reduce disease burden in a Vκ*MYC model of multiple myeloma. BMC Research Notes. 15(1). 352–352. 1 indexed citations

Mobergslien, Anne, Ingrid Moen, Alexander Kristian, et al.. (2022). Tumor growth inhibition and immune system activation following treatment with thorium-227 conjugates and PD-1 check-point inhibition in the MC-38 murine model. Frontiers in Medicine. 9. 1033303–1033303. 6 indexed citations

Moen, Ingrid, Marita Westhrin, Markus Haug, et al.. (2021). Smac-mimetics reduce numbers and viability of human osteoclasts. Cell Death Discovery. 7(1). 36–36. 9 indexed citations

Moen, Ingrid, et al.. (2021). TAK1-inhibitors are cytotoxic for multiple myeloma cells alone and in combination with melphalan. Oncotarget. 12(21). 2158–2168. 7 indexed citations

Moen, Ingrid, et al.. (2015). Anti-metastatic action of FAK inhibitor OXA-11 in combination with VEGFR-2 signaling blockade in pancreatic neuroendocrine tumors. Clinical & Experimental Metastasis. 32(8). 799–817. 15 indexed citations

Moen, Ingrid, Jian Wang, Karl-Henning Kalland, et al.. (2012). Gene expression in tumor cells and stroma in dsRed 4T1 tumors in eGFP-expressing mice with and without enhanced oxygenation. BMC Cancer. 12(1). 21–21. 17 indexed citations

10.

Moen, Ingrid & Linda Stuhr. (2012). Hyperbaric oxygen therapy and cancer—a review. Targeted Oncology. 7(4). 233–242. 237 indexed citations

11.

Moen, Ingrid, et al.. (2011). A reduction in the interstitial fluid pressure per se, does not enhance the uptake of the small molecule weight compound 5-fluorouracil into 4T1 mammary tumours. 1(1). 5–5. 6 indexed citations

12.

Keunen, Olivier, Mikael Johansson, Anaïs Oudin, et al.. (2011). Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma. Proceedings of the National Academy of Sciences. 108(9). 3749–3754. 492 indexed citations breakdown →

13.

Curry, Fitz Roy E., Cecilie Brekke Rygh, Tine V. Karlsen, et al.. (2009). Atrial natriuretic peptide modulation of albumin clearance and contrast agent permeability in mouse skeletal muscle and skin: role in regulation of plasma volume. The Journal of Physiology. 588(2). 325–339. 32 indexed citations

14.

Hasumi, Yoko, Mikhail Burmakin, Aive Åhgren, et al.. (2009). Combined Anti-Angiogenic Therapy Targeting PDGF and VEGF Receptors Lowers the Interstitial Fluid Pressure in a Murine Experimental Carcinoma. PLoS ONE. 4(12). e8149–e8149. 40 indexed citations

15.

Moen, Ingrid, Anne M. Øyan, Karl-Henning Kalland, et al.. (2009). Hyperoxic Treatment Induces Mesenchymal-to-Epithelial Transition in a Rat Adenocarcinoma Model. PLoS ONE. 4(7). e6381–e6381. 59 indexed citations

16.

Stuhr, Linda, Ingrid Moen, Torbjørn Nedrebø, et al.. (2008). Peritumoral TNFα administration influences tumour stroma structure and physiology independently of growth in DMBA‐induced mammary tumours. Scandinavian Journal of Clinical and Laboratory Investigation. 68(7). 602–611. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact